MIF-1

TheraTide USA

$72.99
Availability:
In Stock
Adding to cart… The item has been added

Product Overview

Compound: MIF‑1 (Pro‑Leu‑Gly‑NH₂), also called melanostatin or PLG

Format: 10 mg, 50 mg vials (lyophilized)

For research use only—NOT for human or veterinary use.

Each batch is third‑party tested for ≥98 % purity. COAs are available upon request—email providers@theratideusa.com.

  • Endogenous neuropeptide: Cleaved from oxytocin in the hypothalamus and inhibits MSH release :contentReference[oaicite:1]{index=1}.
  • Dopamine modulator: Acts as an allosteric modulator of D₂/D₄ receptors; influences monoamines :contentReference[oaicite:2]{index=2}.
  • Opioid activity: Exhibits both opiate‑antagonist and agonist effects; studied in anti‑opiate systems :contentReference[oaicite:3]{index=3}.
  • Antidepressant potential: Early clinical trials showed rapid mood improvement; animal and human studies indicate antidepressant effects :contentReference[oaicite:4]{index=4}.
  • Neuroprotective/CNS activity: Activates multiple brain regions via pERK, pSTAT3, and c‑Fos signaling—implicated in Parkinson’s and depression models :contentReference[oaicite:5]{index=5}.
  • Memory & motor support: Enhances learning, neuromotor behavior, and memory in animal models :contentReference[oaicite:6]{index=6}.

Research largely preclinical; human data remain limited but promising.

What is MIF‑1 studied for?
It's researched for depression, Parkinson’s, neuromodulation, motor function, and stress resilience :contentReference[oaicite:7]{index=7}.

How does it work?
It modulates dopamine receptors (D₂/D₄), affects opioid systems, inhibits MSH, and triggers neuro signaling cascades :contentReference[oaicite:8]{index=8}.

Any human evidence?
Small-scale trials (~60 mg/day) reported rapid antidepressant responses in 4 of 5 participants within 2–3 days :contentReference[oaicite:9]{index=9}.

Delivery & dosage?
Not orally active; typically administered via injection in research contexts.

Side effects?
Generally minimal in reported studies; safety data still limited.

For laboratory research use only—not for human or veterinary use, nor as a dietary supplement.

Safety: Handle only under standard lab protocols; store securely.

FDA Notice: These statements have not been evaluated by the FDA; not intended to diagnose, treat, cure, or prevent any disease.

All products offered by TheraTide USA are strictly intended for research and development purposes only.

None of the statements on this website have been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.

TheraTide USA is a research chemical supplier. We are not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.